7-Ewen CL. Kane KP, Bleackley RC. A quarter of a century of granzymes. Cell death. Differ. 2012. 19.28.35.
8-Ikeda H, Old I.J. Schreiber RD. The role of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev. 2002. 13-95.109.
9-Ghoneum M, Matsura M. Augmentation of macrophages phagocytosis by modified arabinoxylan rice bran. Intl. journal of immunology and pharmacology. 2004 17.(3). 283-292.
10-Walzer T, et al. Natural Killer cell-dendritic cell crosstalk in the initiation of immune response. Expert Opin. Ther. 2005.5.5. 49-59.
11-Ghoneum M. Brown. J. NK Immuno-restoration of cancer patients by a modified arabinoxylan rice bran (A study of 32 patients followed for up to 4 years) Int Klatz R Godman R (editors) Anti-aging medical therapeutics. Vol III 1999. 217.228.
12-Ghoneum M, et al. Modified arabinoxylan from rice bran (MGN-3) sensitizes metastatic breast cancer cells to Paclitaxel in vitro. Anticancer Res . 2014.34.81087.
13-Gollapudi S, Ghoneum M. Modified arabinoxylan from rice bran, sensitizes human breast cancer cells to a chemotherapeutic agent, Daunorubicin Cancer Detecte. Prev. 2008.32.16.
14- Serge Jurasunas. NK cell-Based Immunotherapy in the Treatment of Cancer Using a New Arabinoxylan Rice Bran Compound. Townsend Letter. August/Sept 2019. 33-41.
15- Nariman K. Badr El-Din, Said K. Areida, Kvan O. Ahmed and Mamdooh Ghoneum. Arabinoxylan rice bran (MGN3) enhances radiotherapies in animal bearing Ehrlich ascites carcinoma. Journal of Radiation Research. 2019.pp 1-12 16- Ghoneum M, S, Gollapudi. Synergistic apoptotic effect of Arabinoxylan Rice Bran (MGn3) and Curcumin (Turmeric) on human multiple myeloma cell lines. 0266 in vitro. Neoplasia 58.2.2011
For more information:
Email | Blog | Website | Slideshare
See the MOH Disclaimer on page 2
BioBran Interview. Krakov 2017. Dr. Jurasunas